Geode Capital Management
PNT

Geode Capital Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Geode Capital Management’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,900,074
Closed -$12.7M – 4715
2023
Q3 		$12.7M Buy
1,900,074
+174,687
+10% +$1.45M ﹤0.01% 2111
2023
Q2 		$15.6M Buy
1,725,387
+143,952
+9% +$1.27M ﹤0.01% 2022
2023
Q1 		$11.5M Buy
1,581,435
+111,175
+8% +$825K ﹤0.01% 2166
2022
Q4 		$10.7M Buy
1,470,260
+207,662
+16% +$1.54M ﹤0.01% 2224
2022
Q3 		$9.76M Sell
1,262,598
-65,945
-5% -$560K ﹤0.01% 2281
2022
Q2 		$9.05M Buy
1,328,543
+628,860
+90% +$4.81M ﹤0.01% 2325
2022
Q1 		$5.58M Buy
699,683
+78,808
+13% +$500K ﹤0.01% 2733
2021
Q4 		$3.48M Buy
620,875
+109,257
+21% +$820K ﹤0.01% 3090
2021
Q3 		$3.93M Buy
+511,618
New +$4.67M ﹤0.01% 3051

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Geode Capital Management's PNT Position: Q4 2023 in Review

Geode Capital Management sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 1,900,074 shares — an estimated $12.7M sold.

Geode Capital Management first reported a position in PNT in Q3 2021 and held it in 9 quarters. The position peaked at $15.6M in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Geode Capital Management reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Geode Capital Management sold 1,900,074 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $12.7M.
  • Geode Capital Management first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2021 and held it in 9 quarters.
  • Geode Capital Management's POINT Biopharma Global Inc. Common Stock position peaked at $15.6M in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Geode Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.